Novel signalling pathways regulating epithelial-mesenchymal transition in bone metastatic prostate cancer by Rao, SR

Modeling the human bone–tumor niche: reducing and replacing the need for animal data by Rao, SR, Edwards, CM, Edwards, JR

The role of microRNAs in functional osteomimicry in prostate cancer cells by Rao, SR, Hamdy, F, Edwards, C

Transcriptomic and Functional Screens Reveal MicroRNAs That Modulate Prostate Cancer Metastasis by Rao, SR, Howarth, A, Kratschmer, P, Snaith, AE, Yapp, C, Ebner, D, Hamdy, FC, Edwards, CM

Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival by Whitburn, J, Rao, SR, Morris, EV, Tabata, S, Hirayama, A, Soga, T, Edwards, JR, Kaya, Z, Palmer, C, Hamdy, FC, Edwards, CM

Multiple myeloma increases nerve growth factor and other pain-related markers through interactions with the bone microenvironment by Olechnowicz, SWZ, Weivoda, MM, Lwin, ST, Leung, SK, Gooding, S, Nador, G, Javaid, MK, Ramasamy, K, Rao, SR, Edwards, JR, Edwards, CM

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic di... by Charlton, PV, O'Reilly, D, Philippou, Y, Rao, SR, Lamb, ADG, Mills, IG, Higgins, GS, Hamdy, FC, Verrill, C, Buffa, FM, Bryant, RJ

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic di... by Charlton, P, O’Reilly, D, Philippou, Y, Rao, SR, Lamb, AD, Mills, IG, Higgins, G, Hamdy, FC, Verrill, C, Buffa, FM, Bryant, RJ

Genomic evolution and transcriptional changes in the evolution of prostate cancer into neuroendocrine and ductal carcinoma types by Rao, SR, Protheroe, A, Cerundolo, L, Maldonado-Perez, D, Browning, L, Lamb, AD, Bryant, RJ, Mills, IG, Woodcock, DJ, Hamdy, FC, Tomlinson, IPM, Verrill, C

Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden by Cazier, J, Rao, SR, McLean, C, Walker, A, Walker, A, Wright, J, Jaeger, E, Kartsonaki, C, Marsden, L, Yau, C, Camps, C, Kaisaki, P, Taylor, J, Catto, J, Tomlinson, I, Kiltie, A, Hamdy, F

Detailed molecular and immune marker profiling of archival prostate cancer samples reveals an inverse association between TMPRSS2:ERG fusion status and immune cell infiltration by Rao, SR, Alham, NK, Upton, E, McIntyre, S, Bryant, RJ, Cerundolo, L, Bowes, E, Jones, S, Browne, M, Mills, I, Lamb, A, Tomlinson, I, Wedge, D, Browning, L, Sirinukunwattana, K, Palles, C, Hamdy, FC, Rittscher, J, Verrill, C